October 12, 2016
Avecia to acquire California companies
By Sam Bonacci
Nitto Denko Avecia has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio) in an effort to expand its contract manufacturing services.
Avecia, located in Marlborough and Milford, offers manufacturing and development services for therapeutic nucleic acid. The acquisition of the two Irvine California companies, which is expected to close in October and the price of which was not disclosed, will consolidate the two companies into Nitto Avecia Pharma Services. This new company will expand Avecia’s analytical capabilities and complement its existing outsourcing services, according to a release.
WBJ Web Partners
Most Recent
Most Recent
0 Comments